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Metabolomics
The Newest 'Omic Field of Research

Graham Beattie
BCMB409
April 28, 2004

Introduction:
Metabolomics is the latest addition to a recent collection of new scientific fields
that are categorized as 'omic fields of study. Its appearance follows those of genomics
and then proteomics. Genomics is the field that studies the genome, or the entire set of
genes that an organism possesses. Genes are sequences of DNA, and their expression
causes transcription to make mRNA, which codes for proteins. Gene expression studies
involve the profiling of the transcriptome, which is the entire set of mRNA that is present
at any given time in an organism. The mRNA transcripts of the transcriptome are
translated to form proteins. Proteomics deals with studies of the proteome, or the entire
set of proteins that are present in an organism. Metabolites are byproducts of metabolic
reactions that are carried out by proteins. Metabolomics is the study devoted to the
metabolome, which is the entire collection of small molecule metabolites that are present
in an organism at any given time. All of the 'omic fields of study are linked together in
that expression of the genome causes the formation of the transcriptome, which codes for
the proteome, which in tum carries out metabolic activities to cause fluctuations in the
metabolome.
Since metabolites are the end products of gene expression, they are a reflection of
all the collective biochemical processes that are occurring simultaneously in an organism,
and their measurement can give a "snapshot" of the metabolic state and overall health of
an organism. The purpose of this paper is to discuss the technologies and data analysis
techniques that are employed by the field of metabolomics, as well as its application to
multiple scientific disciplines including disease diagnosis, drug discovery, drug
toxicology, functional genomics, systems biology, and nutrition.

2

Technologies:
Nuclear magnetic resonance (NMR) spectroscopy has been used since the late
1950's by chemists to determine the molecular structure of known and unknown
compounds. NMR utilizes a nuclear magnetic resonance spectrometer, which detects
energy absorption by the nuclei of compounds in the sample, and generates a spectrum
with peaks that correlate to absorptions, or resonances. Traditionally, NMR has been
used to detect hydrogen molecules in compounds. The nucleus of hydrogen is a proton,
and it has a nuclear spin of either + 112 or -112. These two spin states normally have the
same energy. When these nuclei are placed in a magnetic field, the energy levels of the
spin states change in such a way that the -112 spin state has higher energy than the +112
spin state. The lower energy of the +112 spin state is favored, and thus more nuclei are in
the + 112 spin state than the -112 spin state under an electrical field. There is now an
energy difference of 8E between the two states. After samples have been placed under a
magnetic field, they are exposed to electromagnetic radiation, typically with a frequency
(v) of 60-500 MHz. Energy is calculated as the product of magnetic field intensity (h)
and frequency (v); Eo=hv. The nlagnetic field in the NMR spectrometer is increased
slowly over time, and the radiation frequency remains constant, causing the energy to
slowly raise over time. When the energy (Eo) is equal to the 8E between the spin states
of the nuclei in the compound, the nuclei in the +1/2 state absorb this energy, causing
thenl to reverse spin and assume the higher energy state of the -112 spin state. When this
occurs, absorption or resonance peaks appear on the spectrum, which is a graph of energy
vs. increasing magnetic field (ppm). Multiple resonance peaks on a spectrum indicate
different groups of chemically inequivalent protons in different parts of the compound.

3

The observed chemical shifts of the different peaks can be compared to tables which
identify the groups making up the conlpound, and this information can then be used to
determine the molecular structure. This is how 1H NMR is used to determine the
molecular structure of compounds. NMR spectroscopy can be used to detect any nucleus
with a spin, including the nuclei of 19F , 31 p , l3C, 14N , and 23 Na . Metabolomicists use
NMR, not only to find molecular structure of compounds, but also to differentiate
between small molecule metabolites in a sample. In this instance resonance peaks can
correspond to entire compounds, not just different groups on one compound (Loudon,
1998).
Ultraviolet (UV) spectroscopy is used to quantify and identify compounds
containing conjugated double bonds. Conjugated double bonds are two double bonds
with only one single bond between them. NMR is not very effective for differentiating
between conjugated double bonds and normal double bonds, so UV spectroscopy must be
used to help determine the structure of compounds containing conjugated double bond
structures. The UV spectrometer generates a UV spectrum of absorbance vs. wavelength
(A). Peaks on the UV spectrum indicate the Amax of the compound, and this value can be

looked up to find what type of diene the compound contains. The absorbance at Amax can
be used for quantification of the compound because the absorbance is related to, and
increases with, the number of molecules in the sample (Loudon, 1998).
Mass spectrometry (MS) is generally used to determine the molecular mass of a
compound, and also to shed light on the molecular structure. The instrument used is a
mass spectrometer, and compounds are vaporized in a vacuum within the device. The
vaporized compounds are then bombarded with a high energy electron beam, causing the
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ejection of an electron from the compound, and the formation of a cation with a + charge.
These cations then undergo a series of fragmentation reactions in each of which one atom
is removed from the compound until it is completely degraded to an individual cation.
This degradation process yields many fragmentation cations along the way, which are
separated by their mass-to-charge ratios (mlz) by the mass spectrometer. Since the
charge is generally +1, the mlz ratio correlates to the mass of each cation. A mass
spectrum is then generated, which is a graph of the relative abundance of each cation vs.
their mlz ratios. The ion on the spectrum with the highest m/z value is called the
molecular ion, and corresponds to the cation initially formed by the ejection of an
electron form the complete compound. The mass of the molecular ion is equal to the
mass of the original compound. The masses of the other cations on the mass spectrun1
can then be used to determine the identity and quantity of the atoms making up the
compound by looking at the mass difference between the cations to see what type of atom
was removed at each subsequent fragmentation reaction. This gives enough information
to determine the molecular formula and a partial structure of the compound.
Metabolomicists use separation techniques to purify and separate small molecule
metabolites in a sample from each other. Once separated, the individual metabolites can
be analyzed by mass spectrometry to give their molecular mass, molecular formula, and
partial molecular structure (Loudon, 1998).
High performance liquid chromatography (HPLC) is a separation technique that
can be used to separate and purify compounds in a mixture based on charge,
hydrophobicity, size, or affinity for certain molecules. HPLC utilizes a uniform column
bed that is packed with tiny spheres designed to separate mixtures based on one of these

5

characteristics. The sample is placed in a solvent, and then run through the machine at a
rate of one column volume per minute. The nature of the material in the column slows
some compounds passing through, while allowing others to pass through at faster rates or
freely. The HPLC machine automatically places eluted solvent in different tubes based
on time of elution. A readout from the machine indicates which tubes have accumulation
of compounds in them. These tubes should contain purified collection of compounds
because different compounds will be eluted into different tubes due to their differential
rate of flow through the column. Gas chromatography (GC) is another separation
technique, which separates mixtures based on the boiling points of the components.
Mixtures are injected into an injection port, which is.maintained at a temperature higher
than the boiling point of the compounds in the sample. The components of the sample
vaporize differentially based on their boiling points, and are then carried through a
column by an inert gas. When compounds pass through the column, they are detected by
a detector, which relays this information to a recorder. This is similar to the detection of
compound elution in HPLC. The two types of columns utilized in GC include packed
columns and capillary columns. Packed columns are 1-5 m in length and 5 mm in
diameter. Capillary columns are 10-100 m long and have an inner diameter of 250 /-tm.
Capillary columns have a higher separation efficiency, and are thus more suited for
metabolomic studies (Alberts et ai., 2002). The purified samples eluted from the
separation techniques of HPLC and GC can then be analyzed by MS for metabolomic
studies.
NMR and MS are the two platforms for metabolite analysis that are used most
frequently in the field of metabolomics. UV is used in conjunction for structural
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detennination only when the metabolite compounds of interest contain conjugated double
bonds, causing the failure ofNMR to reveal accurate structures. There are several
advantages to the use ofNMR over MS. These include identification and quantification
of metabolites in complex mixtures without the necessity for sample preprocessing by
separation techniques, and its relatively low time consumption (Adams, 2003). NMR is
also advantageous in its ability to specifically detect and identify compounds containing
nuclei with proton spin, which is a characteristic of the vast majority of metabolites
(Sumner et af., 2003). Additionally, NMR has the capacity to detect hundreds of small
molecule metabolites simultaneously, and its non-destructive nature allows metabolite
detection and localization of the individual metabolites within cells, tissues, and organs.
The drawback to NMR is its requirement for relatively high analyte concentrations for
detection, meaning that it is difficult to identify the metabolites that are naturally low in
concentration (Watkins and Gennan, 2002). Alternatively, MS is capable of identifying
and quantifying metabolites in samples regardless of how low their concentrations may
be. The drawback of MS is the fact that it cannot identify or quantify individual
metabolites within a mixed sample, and samples must first be processed by separation
techniques to give purified metabolite samples for MS analysis (Adams, 2003). Neither
NMR nor MS offer good means of metabolite identification and quantification on their
own, and there is no other single technique that is capable of effective metabolomic
analyses. For successful identification and quantification of all metabolite classes,
modifications on existing technologies or hyphenated techniques must be utilized (NIH,
2003).
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Several modifications on NMR techniques have been established for better
metabolite detection. One of these is the use of BC NMR for tracking BC-Iabeled
metabolites through metabolic networks to reveal network topologies (Grivet et al.,
2003). Another example of an NMR modification that was found to increase resolution
for accurate metabolite identification was two-dimensional (2D) J-resolved (JRES) NMR.
2D JRES NMR can offer higher resolution by analyzing the skyline projection of the
JRES spectrum, which has separate axes for chemical shift and spin-spin coupling data
for the reduction of background noise on the spectrum. This technology was used to
determine the relative levels of citrate, taurine, and alanine throughout the different stages
ofmedaka embryogenesis (Viant, 2003). Other modifications ofNMR techniques that
have been utilized for better metabolite detection include 2D IH NMR, in situ IH NMR,
and 2D IH_BC NMR (Grivet et ai., 2003).
Many combinatory or hyphenated techniques have been used to increase the
usefulness of MS in metabolomic studies as well. GC-MS has been around for a long
time, but it is not capable of high throughput, meaning that it is time consuming. The
incorporation ofa time of flight (TOF) mass spectrometer into the GC-MS method has
been shown to greatly increase the throughput of metabolite detection because the TOF
mass spectronleter has the capacity to generate more than 50 spectra per second (Guttman

et al., 2004). A study that was aimed at the detection of all detectable metabolites in the
model plant Arabidopsis thaliana compared the success of detection using different
hyphenated MS techniques. These techniques included GC-MS, capillary electrophoresis
(CE)-MS, and HPLC-MS. Using simple GC-MS, 300 of the estimated 5000 metabolites
in Arabidopsis thaliana were detected. Three different methods of CE-MS were studied,
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and they collectively detected approximately 1500 nletabolites. The unavailability of CE
technology in normal labs lead to the overall preference of metabolite detection in the
plant extracts by HPLC-MS, a technique that is more sensitive than GC-MS, and more
reasonable than CE-MS. Experimentation with different types ofHPLC columns were
undertaken, and they revealed that hydrophilic interaction columns were best suited for
detection of polar and water-soluble metabolites, and reversed-phase columns were the
most suitable for detection of metabolites rich in lipophilic component content. The
study discovered that the use of monolithic silica C18 capillary columns could decrease
time consumption relative to normal particle-packed columns due to the increased porous
nature of the capillary column material, while simultaneously increasing resolution of
peaks for metabolite detection. Experiments with monolithic silica C 18 capillary
columns that were 30 cm, 60 cm, and 90 cm long showed that increased column length in
monolithic C18 reversed-phase HPLC-MS slightly decreased the time efficiency and
throughput, but greatly increased the resolution of peaks for successful identification of
lipophilic metabolite classes in crude plant extracts (Tolstikov et at., 2003). Other
hyphenated techniques involving MS that have shown improvement in metabolite
detection experiments include liquid chromatography tandem mass spectrometry (LCMS-MS), Fourier transform ion cyclotron mass spectrometry (FTMS), HPLC-NMR-MS,
and HPLC-NMR-MS-MS (Sumner et at., 2003).
The national institute of health has recognized the potential application of
metabolonlics to numerous scientific fields of study, as well as the inherent problems
with existing technology used for metabolomic studies in relation to their quantification,
scope, and throughput capacities. They have published a solicitation that offers
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researchers grant nloney for the developnlent of an integrated set of technologies well
suited for metabolomic studies (NIH, 2003).

Data Analysis:
NMR and MS spectral data can be analyzed by computers that perform principle
component analysis (PCA) to create PCA plots. The computer analyzes the data and
assigns principle component (PC) values to the variables, in this case the metabolites, that
describe the greatest variance between data sets. When the PCs are plotted on separate
axes of a graph, the resulting scores plot can reveal patterns within a group that are useful
to researchers for later comparison in future studies. A similar technique is that of Soft
Independent Modeling of Class Analogy (SIMCA), which is used to create computer
generated models with similar results to those of PC A (Reo,2002).
Another data analysis method is that of Heirarchical cluster analysis (HCA). In
this type of analysis, conlputers generate dendograms illustrating the groups of similar
metabolites, and their distance from each other based on a number of distance measures.
Self organizing maps (SOMs) are an ideal means of spectral data analysis in that they
utilize artificial intelligence in computers for better group differentiation based on
similarities of data sets within groups, and superior visualization when compared to PCA,
SIMCA, or HCA (Sumner et al., 2003).

Disease Study and Diagnosis:
There are many diseases in all different types of organisms that are metabolic in
origin, meaning that they are not caused by infectious pathogens, such as different kinds
of viral, fungal, or bacterial agents. The origins of metabolic disease lie in the
environmental influences on metabolism. Organisms that are developing metabolic
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diseases will have altered metabolism compared to those deemed healthy. The
metabolome will shift in the concentration of certain metabolites during the development
of metabolic disease in a way that is indicative of what type of metabolic disease is
affecting an organism. Metabolomic profiling can indicate differences in the
metabolomes of healthy and diseased individuals, therefore identifying biomarkers for
the disease, and creating a basis of comparison that can be used to diagnose others
similarly (Viant et al., 2003).

An example of a metabolomic study on disease is illustrated by a study that
focused on withering syndrome in the red abalone, a Pacific shellfish. Withering
syndrome is caused by a pathogen called Rickettsiales-like prokaryote (RLP), which
infects the digestive epithelial cells, leading to death from subsequent onset of withering
syndrome. Withering syndrome is unlike normal metabolic diseases because it requires
the infection with a pathogen before disease can occur. It does, however, bear some
similarity with environmentally induced metabolic diseases, since there is a much higher
rate of withering syndrome in red abalone that are in the presence of environmental
attenuators of stress. The environmental factors that can affect the onset of withering
syndrome include seawater temperature and quality. When the combination of infection
by an RLP and environmental stress occur simultaneously, it is very likely that withering
syndrome will set in as the disease state, in which it exerts its effects on abalone's
metabolism. For this study, samples of foot muscle, digestive gland, and hemolymph
samples were taken from diseased, stunted, and healthy abalone for metabolic profiling
purposes. All of the samples were analyzed by IH NMR, yielding hundreds of peaks on
the NMR spectra that corresponded to specific metabolites. Principle component
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analyses were conducted on the NMR spectra in order to reduce the data set to those
metabolites that were significant due to either similarities or differences between spectra.
PCA score plots of the principle components were then generated by a computer, and
clustering of data points lead to three visible clusters that represented the principle
components of the data collected via NMR from diseased, stunted, and healthy abalone.
This illustrates that the health of an abalone could be determined by NMR and PCA score
plots without ever actually identifying the principle components. This held true for all
tissue and hemolymph samples. Although it was not necessary to identify any of the
metabolites that were represented by peaks on the NMR spectra for the diagnosis of
withering syndrome, the identity of the metabolite that had the greatest variability
between the healthy and diseased states was determined. This metabolite was homarine,
which was shown to increase in the diseased and stunted abalone relative to its lowest
concentration in the healthy abalone. Homarine can be used as a biomarker for the
progression towards withering syndrome in red abalone. This study provided disease
diagnosis methods for withering syndrome in red abalone. These include NMR spectra
and subsequent PCA plots for comparison in future studies. Another method that can be
utilized now, after establishing that homarine is a biomarker for disease and noting that
glycine levels dropped in all of diseased and stunted samples, is HPLC for the
determination of glycine to homarine ratios, which would become smaller as the disease
state increases (Viant et al., 2003). This method of profiling in diseased and healthy
organisms could be extended to study other metabolic diseases in the future, and lead to
the discovery of new biomarkers of disease.

12

Metabolomic mapping is another method that can be used to study the differences
in biochemical processes that occur in diseased vs. healthy organisms. Metabolomic
mapping can follow the individual components a known initial amount of a specific
metabolite through all of the different biochemical pathways they are involved in
throughout the body to determine the final destinations of all the metabolites in the initial
pool. This can be achieved by injecting a known concentration of a single metabolite
into healthy and diseased individuals, and then tracking their differential movement
through organs, tissues, cell types, and subcellular compartments in the healthy and
diseases individuals. This can reveal the biochemical processes that have taken place,
and identify metabolite distributions that are correlated with healthy and diseased states
(Nishikawa et aI., 2003).

An example ofmetabolomic mapping for disease study in mammals can be seen
in a study that mapped vitanlin C in diabetic and normal rats. L-ascorbic acid (ASA) is a
form of vitamin C, and it is known to occur at lower concentrations in the plasma and
tissues of diabetic individuals in comparison to its higher abundance in plasma and tissue
of healthy individuals. This holds true for diabetic rats as well as diabetic humans.
Lower ASA levels in diabetics suggest that ASA is degraded more rapidly in diabetics
than it is in healthy individuals. In the presence of free radicals, ASA is normally
oxidized to form dehydro-L-ascorbic acid (DHA). This is the mechanism by which ASA
participates in oxidant defense, and its oxidized form ofDHA is normally reduced to its
original form. In situations of high free radical abundance, accumulated DHA can be
converted into diketo-L-gulonic acid (DKG). This is a delactonization reaction and is
irreversible. Numerous subsequent DKG degradation products are formed after
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delactonization ofDHA has occurred. This study utilized NMR to follow the distribution
and degradation of ASA that was labeled with a 19F isotope. Labeling was necessary to
discriminate between injected ASA and naturally occurring ASA. Labeling the ASA with
the 19F isotope also made for easy detection, quantification, and identification by the
highly sensitive method of 19F NMR. The labeled fonn of ASA used was 6-deoxyfluoro-ascorbic acid (F-ASA), and it was shown to have the same structural confonnation
and exhibited similar degradation behavior to natural ASA. It is hypothesized that
increased oxidative stress in diabetic individuals is the cause of lower ASA levels. If
oxidative stress is the cause of ASA loss in diabetics, then the final destination of the
ASA metabolites that are lost should be the mUltiple DKG degradation products. ASA
can alternatively be degraded by a metal catalyzed oxidation reaction. This study
mapped F-ASA degradation in diabetic and healthy rats to detennine the mechanisms of
F-ASA degradation that occurred in these individuals based on the degradation end
products. The metal catalyzed degradation products ofF-ASA were analyzed by 19F
NMR after incubation ofF-ASA in PBS with Cu2+. Four stable degradation compounds
were detected for Cu2+ degradation ofF-ASA, with the major degradation compound
producing a resonance peak at -212.45 ppm. When F-DHA was incubated in similar
conditions, the major initial degradation product was found at -213.4 ppm, and was
converted later to the -212.45 ppm degradation product. The results of these two
degradation experiments show that metal catalyzed degradation ofF-ASA does not rely
on F-DHA as an intennediate like it does under conditions of oxidative stress. One of the
major differences in the F-ASA distribution between diabetic and healthy rats that was
uncovered in this study was that F-ASA concentrations were much lower in the plasma,
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kidney, and spleen of the diabetic rats. Metabolomic mapping revealed that the lowered
level ofF-ASA in these areas was due to urinary loss ofF-ASA. It was determined that
40% of the F-ASA injected into diabetic rats was lost in the urine within one day. This
can be compared to 18% F-ASA lost in the urine of healthy rats at 24 hours.

19F

NMR

was used to analyze the urine of the healthy and diabetic rats. The healthy rat urine
contained F-DKG degradation products, F-l through F-7, but the diabetic rat urine was
missing some of the F-DKG degradation compounds between F-4 and F-7. This
evidence suggests that diabetics have not only accelerated F-ASA degradation and loss,
but also less complex degradation processes that is similar, but not idendical, to
degradation from oxidative stress. To determine whether the degradation products were
of biologic origin or a result of in situ degradation in the urine, F-ASA was incubated in
normal and diabetic rat urine for one day, and the degradation products were observed.
The degradation products that resulted from F-ASA incubation in rat urine were similar
to those of metal catalyzed degradation experiments, but not similar to the products found
in the rat urine 24 hours after injection. This study shows that accelerated nonmetal
catalyzed ASA degradation of biological origin in diabetics is the cause of lower plasma,
kidney, and spleen levels of ASA. It also demonstrated the differences in the urinary
degradation compounds of ASA in healthy vs. diabetic rats, which suggests that urine
analysis could be used for diagnosis of diabetes in the future (Nishikawa et al., 2003).
Metabolomic mapping could be utilized to study the effects of numerous other metabolic
diseases, and has the potential to increase knowledge of disease mechanisms, and identify
new methods of diagnosis.
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Drug Discovery:
Metabolomics has the potential to be useful in the pharmaceutical arena by aiding
in the process of drug discovery. One way in which metabolomics could be useful for
drug discovery is by conducting metabolomic studies on disease mechanisms to elucidate
new drug targets. An example of this type ofmetabolomic study can be seen in the study
of hypoxia-inducible factor 1 (HIF-l), which is a transcription factor involved in the
progression ofnlany cancers. The heterodimer HIF-l, which is over-expressed in
cancerous cells, is made up of a and

p subunits.

This study compared the metabolomes

of normal Hepatonla cells with those deficient in their HIF-IP subunits (Hepa c4 cells).
Hepa c4 tumors have slowed rates of growth when compared to normal Hepatoma
tumors. NMR analysis of tumor extracts revealed that Hepa c4 cells have lower
concentrations of glycine, betaine, and cholines. These are results of the failure to
upregulate glycolysis in the Hepa c4 cells, while it is upregulated in normal Hepatoma
cells and numerous other types of cancerous cells. Glycine is required for purine ring
synthesis, and purines are required for ATP synthesis. The ATP content of the Hepa c4
cells was 20% of the A TP content in normal Hepatoma cells. ATP is necessary for cell
proliferation and tumor growth, and the lack of A TP in the Hepa c4 cells can account for
the slowed growth rate in Hepa c4 tumors. This study, which illustrated that HIF-l p
deficient Hepatoma tumors have slowed rates of growth due to their failure to upregulate
glycolysis for ATP production, shows that the HIF-l transcription factor could be a good
drug target to slow the progression of cancer and decrease the rate of tumor growth
(Griffiths and Stubbs, 2003).
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Metabolomics could also be useful in drug discovery by offering a method of
screening the plant kingdom for naturally occurring bioactive compounds. Natural
products of plants and their derivatives currently make up over 40% of the drugs
designed in the pharmaceutical arena, yet only a miniscule portion of the 350,000 known
plant species have been researched for therapeutic activity. LC-UV-MS and LC-NMR
profiling techniques can be used along with LC-bioactivity assays to identify bioactive
compounds in crude plant extracts. This can be seen in a study that screened crude plant
extracts from an African plant, Erythrina vogelii, for antifungal agents with bioactivity
against Cladosporium cucumerinum. These techniques were used to identify nine
compounds that exhibited antifungal activity in LC-bioactivity assays with Cladosporium

cucumerinum. The dereplication process of comparing these compounds to libraries of
known antifungal agents revealed that two of these compounds were previously
unknown. This study successfully identified an isoflavone and an isoflavanone as
previously unknown antifungal agents (Wolfender et al., 2003). This type of analysis of
crude plant extracts could be replicated in additional plant species for antifungal activity
against additional fungal pathogens, as well as other types of pathogens. This could lead
to a future advance in the rate of discovery of naturally occurring therapeutic agents that
can be used as templates for new drug designs.

Drug Toxicology:
Drugs are not perfect in the sense that they may affect numerous biochemical
pathways, in addition to the ones they are designed to alter. Even when a drug can
successfully cause desired changes in metabolism, it can alter other aspects of
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metabolism that eventually lead to detrimental effects. Drug induced toxicity can occur
when long term drug therapies lead to chronic metabolite imbalances and cause negative
side-effects such as disease. By monitoring changes in metabolite concentrations, it is
possible to determine which metabolic pathways are unintentionally affected by drug
therapies and indicate when drugs have to potential to cause toxic effects. This is not a
new concept, and in fact, succinate, glycine, and dimethyl amine levels in blood are
already measured in their response to drug therapies because it is known that their
presence in blood can predict kidney damage. It is inlportant that other metabolites
correlated with toxic effects be identified so that potentially toxic drugs never reach the
public. Paradigm Genetics is a company that has created a predictive toxicology program
for just that purpose, and they hope to identify shifts in the metabolome content that are
characteristic of ill effects (Adams, 2003).

Metabonomics is a subdivision of metabolomics that is dedicated to the study of
drug toxicity through the utilization ofNMR for analysis of the metabolome and
subsequent pattern recognition methods to identify toxic effects. The pattern recognition
methods, like PCA, are useful for the determination of the toxin type, since different
types of toxins cause different types of shifts in metabolite concentrations within the
metabolome. Metabolite patterns that are indicative of toxic effects can be identified by
using NMR to determine the metabolite concentration changes that occur after exposing
an organism to multiple known toxins, followed by principle component analysis. These
PCA plots can be used as a reference for conlparison when analyzing the effects of drug
treatments to determine whether they are potentially toxic, and to determine the type of
toxic effect that may occur. These types of studies have already identified some
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metabolite patterns that are indicative of toxicity such as the correlation between toxic
damage to the proximal tubules in the renal cortex with appearance of glucose, amino
acids, and some organic acids in urine samples, as well as the correlation between renal
or hepato-toxins with lowered concentrations of urinary citrate. Metabonomics can also
be used to identify individuals that are more likely to have negative side-effects to drug
therapies which may not cause harm to some people. This can be done by analyzing the
metabolites in urine samples of different individuals to determine whether the potentially
toxic effects of a drug therapy are more or less likely to cause harmful inlbalances in their
metabolomes. For example, a study of the urinary metabolomes in two different mouse
strains, Alpk:ApfCK and C57BLIOJ, was able to identify differential characteristics of
the metabolomes, which may make them more or less at risk for drug induced toxicities.
NMR analysis and PCA can be very effective for identifying toxic effects of drug
treatments, and offer a superior method to previously used clinical chemistry methods.
This is due to their increased sensitivity and ability to observe changes indicative of
toxicity when clinical chemistry cannot (Reo, 2002).

A specific example of a drug that has been shown to have toxic effects through
metabolomic studies is that of rosiglitazone, a type II diabetes drug. This drug was
designed with the purpose of lowering the levels of serum glucose, insulin, and
triacylglycerides, which are all unusually high in the serum of individuals with type II
diabetes. Rosiglitazone can successfully lower these levels, but metabolomic studies
have revealed that the drug treatment does not lower them in a beneficial way, and can
actually cause more harm than good. Metabolomic analyses revealed the mechanism of
action which rosiglitazone uses to lower plasma triacylglyceride levels, which was the
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blocking of lipid export into blood. Although plasma analysis would indicate positive
effects of the drug, it actually causes an increase in fatty acid synthesis, leading to higher
fat content in liver and adipose in comparison to their fat contents in type II diabetics
prior to drug treatment. Rosiglitazone is an example of a drug that has been identified
through metabolomics as one that not only does not achieve its desired effects in an
appropriate way, but as one that causes more harm than good by increasing overall fat
content to cause negative side effects such as hepatic lipidosis (German et at., 2003a).
Future metabolomic studies will be able to identify additional drug duds that do not lead
to their intended effects through appropriate means of intervention.

Functional Genomics:
Genomics is the field of study dealing with studies of the genome, which is the
entire set of genes that an organism possesses. Functional Genomics the subdivision of
the genomics field in which specific unidentified genes are studied with the purpose of
determining their functional role in an organism. DNA sequencing techniques sparked
the beginning of the genomics era, which has had a huge impact on science and advanced
numerous disciplines in the scientific arena. Functional Genomics relies on gene
expression studies that analyze the mRNA content of the transcriptome in order to
construct an mRNA profile for the organism under study (Sumner et al., 2003). This is
done by utilizing DNA microarray technology, which has revolutionized gene expression
studies, and allowed the simultaneous detection of the expression or repression of
thousands of genes simultaneously on a tiny specialized gene chip. By studying the
expression of specific gene sets in organisms that have been exposed to different
conditions or modified genetically, microarrays provide functional genomicists a
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powerful tool for predicting the functions of individual genes with known sequences
(Foos et al., 2003).
Arabidopsis thaliana is a model plant and is one of the twenty plus organisms
with genomes that have been completely sequenced since the invention of automated
DNA sequencing. By strategically perturbing genes of interest, and studying the
resulting changes in the various gene expression products, functional genomicists have
been successful in identifying the functions of vast amounts of genes. Several
characteristics of plants make them ideal organisms for gene expression studies.
Chemical exposure, ionizing radiation exposure, and foreign DNA incorporation are all
methods used to mutate genes of interest for gene expression studies in plants. It is much
easier to cause these mutations in plants than in animals, and it also does not upset
anyone over the use of animals for experimental research. The mRNA making up the
transcriptome, proteins making up the proteome, and metabolites making up the
metabolome represent a cascade of gene expression products in an organism. Studying
changes in these products relative to the types of mutations that were induced can help
researchers elucidate genes that are related to each other, as well as their function.
Another approach to determining gene functions is by assigning genes predicted
functions based on sequence similarities with other genes that have already been
functionally identified. Although these methods have been successful in identifying
functions of a portion of the genes in Arabidopsis thaliana, not very many of the genes
assigned functions have been confirmed to have their predicted functions through
experimentation, and many more have not been assigned predicted functions at all
(Sumner et aI., 2003).
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Phenotypes can be determined by measuring the changes in metabolite
concentrations that occur as a result of gene expression and protein activities.
Metabolites are a good measure of what type of post-transcriptional response to gene
expression takes place in a cell or tissue. Metabolites can alter in concentration as a
result of a biochemical pathway, which was modulated by gene expression, and
identification of the pathway responsible for altering the metabolome can be very useful
for assigning functions to genes that directly affect metabolism (Sumner et at., 2003). An
example of this type of gene activity can bee seen by the changes in concentrations of
several nitrogenous metabolites during diurnal changes in plants, which are the result of
altered nitrogen metabolism pathways (Stitt and Fernie, 2003). When gene expression
does not dictate the activity of proteins, or cause changes in metabolite concentrations,
there is a good chance that the protein must be activated at the post-transcriptional level
(Sumner et at., 2003). This can be seen in nitrate reductase, which is regulated post
transcriptionally by various methods involving sugar, light, or carbon dioxide, as well as
members of the 14-3-3 protein family. In another example, glutamine synthetase is
regulated post-transcriptionally by shifts in the concentration of ammonium metabolites.
Some genes that exert effects on metabolism do so in such a way that it is impossible to
detect any changes in the proteome. Because of their superior sensitivity, metabolomic
detections of metabolite concentration changes can be very useful in these circumstances
to reveal what has occurred, which can then indicate the specific gene function (Stitt and
Fernie,2003). So, metabolomics can be very useful for determining gene functions when
the gene directly effects metabolism, the gene produces proteins that are regulated post-
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transcriptionally, and when the activity of the protein is so acute that it can only be
detected at the metabolite level.
Metabolomic strategies for functional genomics are based on metabolic profiling,
and have the potential to accelerate the rate of gene function discovery in plants by
determining gene function based solely on the detection and analysis of the metabolome
without conducting studies on the transcriptome and proteome. This is partly due to the
metabolite richness in plants that is acquired through the numerous different metabolic
reactions that can be carried out by an individual protein in different subcellular
compartments. Plants are said to have between twenty and fifty thousand genes in their
genomes, and are estimated to have tens of thousands of metabolites, with an estimated
200,000 different metabolites throughout the entire plant kingdom (Hall et ai., 2002).
The metabolomic functional genomic process should begin with the identification and
quantification of the metabolites that shift in concentration due to a series of genetic
perturbations. The metabolites that should be targeted for detection in these experiments
should include carbohydrates, amino acids, organic acids, lipids, fatty acid constituents,
vitamins, phenylpropanoids, terpenoids, alkaloids, and glucosinolates. After metabolite
detection, researchers should look for groups of metabolites that seem to vary in their
concentrations after similar perturbations, and decide which metabolic reactions they are
involved in to assign gene functions (Sumner et ai., 2003).
Data acquisition methods for metabolite profiling in plants need to include means
to collect accurate samples from different subcellular compartments because there are
differential reactions displayed in the different subcellular compartments, causing each to
have its own unique metabolome. Methods include traditional microdissection, and a
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biochemical process that causes subcellular components to break away from each other,
and uses a device to detect markers in each so their origin can be identified after
completion. NMR spectroscopy can be used to detect metabolites in some of the
different subcellular compartments without harming the cells or altering their
composition (Stitt and Fernie, 2003). Most metabolite detection techniques related to
functional genomics are conducted on plant extracts. The two most commonly used
methods for this detection are GC-MS and HPLC-photodiode array-MS because of their
reliability in identification of abundance and metabolite class for metabolic profiling. By
incorporating TOF technology and peak deconvolution software into GC-MS
measurements, increased resolution can was achieved, which doubled the quantity of
metabolites that could be detected in crude plant extracts (Hall et al., 2002).
FANCY was coined by Steve Oliver, and represents a metabolomic approach for
assessing gene functions in yeast. FANCY stands for functional analysis by co-response
in yeast, and assigns gene functions similar to the functions of known genes when they
exhibit a co-response. A co-response is indicated by similar changes in metabolite
concentrations in an organism when unknown and known genes are perturbed at different
times. FANCY assigns functions as to which biochemical pathways the gene is involved
in (Sumner et ai., 2003). It seems likely that FANCY techniques could be implemented
for gene function determination in plants in the same way that it has bee used in yeast. A
study that was presented by Denise Jacobs at the First International Congress on Plant
Metabolomics showed evidence that FANCY for plants is a feasible approach. She
conducted genetic pertubations in 2000 various genes of Catharanthus roseus to alter the
proteome, and saw the similar co-response of alkaloid accumulation for approximately

24

one third of the trials, which shows that genes with co-responses to perturbations do not
just reside in yeast (Hall et al., 2002).
Transgenic plants, in which foreign DNA has been integrated with the native
genomic DNA, are used for metabolomic studies directed towards the elucidation of gene
functions through the measurement and analysis of changes in the metabolome that result
from the incorporation of a transgene. A functional genomics study, which was
conducted at Plant Research International in the Netherlands, utilized transgenic tomato
plants that were designed to overexpress the Lc/C 1 transcription factor. The researchers
constructed metabolic profiles of normal tomatoes and transgenic tomatoes by analyzing
crude plant extracts with four different hyphenated techniques for metabolite detection,
quantification, and identification. The techniques used in this study included the
combinatory technologies of LC/photodiode array detection, LC-TOF-MS, direct
infusion-TOF-MS, and GC-MS. The data that was obtained from this study correlated
overexpression of the Lc/C 1 transcription factor to extremely high levels of accumulation
of flavonoids, as well as an accumulation ofmethylsalicylate (Hall et ai., 2002). These
findings give the researchers a basis for assigning gene function to Lc/C 1 through
determination of the biochemical pathways that were activated to cause these metabolite
accumulations.
Knockout mutations are another type of genetic modification that can be utilized
in plants for functional analysis of genes by metabolomic study. The term knockout in
this sense generally characterizes the underexpression of a specific gene within the
genome in order to ascertain the effects of its activity absence on the phenotype of the
organism. Knockouts will help elucidate gene function if the gene of study cannot be
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deleted because that gene is one that the organism cannot live without. RNA interference
can successfully cause knockout effects by antisense inhibition of gene expression, where
a molecule binds specifically to the mRNA transcript of the gene under study and blocks
translation, preventing protein assembly (Stitt and Fernie, 2003). Knockout mutant plants
provide the metabolonlic analysis of gene function a contrast to the transgenic plant
mutations, because the certain gene of interest is not expressed due to antisense
inhibition, rather than inserted as a duplicate and overexpressed. In these types of
experiments, researchers should generally see a drop in the concentration of the
metabolites that the knocked out gene is normally responsible for forming as a result of
its expression. An example of a metabolomic knockout experiment determining gene
function can be seen above in the study that implicated hundreds of genes in the
accumulation of alkaloids in Catharanthus roseus (Hall et al., 2002). Metabolomic
profiling in knockout mutants has lead to the discovery of additional functions of some
genes that were already functionally annotated. Transketolase has been characterized as
an important enzyme in the Calvin cycle for a long time, but metabolic profiling of
Transketolase knockouts have shown that it also exerts effects on the regulation of the
shikimic acid pathway, as well as phenylpropanoid metabolism (Stitt and Fernie, 2003).
Functional genomics is not only capable of defining the functions of individual
genes, but also will be able to interrelate different genes that work together, and
characterize the connectivity between multiple genes, biochemical pathways, and
metabolites for a better understanding of the features of entire biological systems. This
type of functional genomics is called integrated functional genomics, and will be largely
based on metabolomic studies. In response to the metabolomic advancements of
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functional genomics, The Samuel Roberts Noble Foundation has started an integrated
functional genomics program, and other integrated functional genomics programs are
sprouting up at Iowa State University, the University of Massachusetts, the Max Plank
Institute, and the Plant Research Institute (Hall et al., 2002).

Systems Biology:
The goal of systems biology is to develop enough knowledge about all of the
different biochemical processes and networks that exist within cells, tissues, and
organisms to get a good understanding of all the aspects of an entire integrated biological
system. The goals of systems biology are quite sinlilar to those of integrated functional
genomics, which are described above. The methods for data collection in systems
biology bear great similarity to those employed by functional genomics in that both study
the effects of genetic perturbations in plant genomes through quantitative measurement
and identification of the response in the metabolome (Weckwerth, 2003). While the goal
of functional genomics, to identify individual gene function, can be attained without
measuring changes in the transcriptome and proteome, these measurements must be taken
for information to be accumulated regarding all biological processes enconlpassed by
systems biology (Sumner et al., 2003). The metabolomic data acquisition processes
employed by functional genomics and systems biology differ in one fundamental way.
Functional genomics relies on metabolic profiling in which there is a known group of
targets for analysis, while the metabolomic aspect of systems biology is based on the
global analysis of all metabolites present in an unbiased way (Weckwerth, 2003).
Due to the heterogeneous tissue makeup of plants and the existence of subcellular
compartments within plant cells, there are numerous different concentration gradients of

27

metabolites within cells and tissues (Weckwerth, 2003). This makes analysis of
metabolites in unbiased ways difficult, and it is necessary to analyze the individual
metabolomes of different subcellular compartments, cell types, and tissue types for
accurate data that describes the variability of enzyme activity for creation of a picture of
the processes that take place throughout the entire system (Sumner et ai., 2003). An
experiment in which plastid phosphoglucomutase was under-expressed illustrates the
differential activity of single enzymes in different subcellular organelles. In addition to
various other metabolic changes, the decresed expression of phosphoglucomutase
increased amino acid synthesis in the plastid, while simultaneously decreasing amino acid
synthesis in all the other subcellular organelles (Stitt and Fernie, 2003).
In some respects, this non-targeted analysis of metabolite components in systems

biology is a superior technique to the existing techniques oftranscriptome and proteome
profiling that have been used for systems biology in the past. The technology available
for metabolite profiling allows for correct metabolite quantification and identification
with relative ease, while methods of mRNA profiling and protein profiling used in the
past have been far more involved and difficult (Weckwerth, 2003). mRNA profiling has,
however, advanced tremendously since the invention of DNA microarrays, and
companies are beginning to offer protein arrays as well (Foos et ai., 2003). These new
platforms for studying the transcriptome, proteome, and metabolome stand to make
significant advances in the quantity of complex biological processes that are discovered
in a system-wide manner.
Identifying network connectivity between mUltiple pathways is crucial to the
advancement of systems biology. It is a common misconception that genes drive entire
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biological systems (Weckwerth, 2003). Changes in the expression of genes or the
transcriptome usually lead to changes in the proteome and metabolome as well, but there
are many cases where this is not true due to post-transcriptional regulation or cross-talk
between pathways (Stitt and Fernie, 2003). The multiple data sets that are required for
analysis of entire systems include measurements of the transcriptome, proteome, and
multiple metabolomes of tissues, cells, and organelles. These, combined with knowledge
of growth stages, environment, and diurnal/circadian rhythmicity must be compiled and
integrated to understand all biological processes that occur in an organisnl simultaneously
(Weckwerth, 2003).
Although the preferred techniques for metabolite identification and quantification
are usually GC-MS and LC-MS, the holistic approach of systems biology requires
implementation of multiple techniques that are suited for certain types of metabolites.
This is because systems biology requires an unbiased global analysis of metabolites, and
the two most popular techniques, although very effective usually, lack in their ability to
detect and analyze certain metabolite classes. Ionic compounds have been identified and
quantified by CE-MS, which has much higher resolution for these than either GC-MS or
LC-MS. One study showed that normally undetected saponins can be quantified and
identified by using electrospray ionization (ESn-LC-MS-MS to reveal their variance in
different species of Medicago. By sampling from the multiple sites that vary in their
metabolomes, it is possible to track metabolites through organisms to reveal network
topologies. After initial sampling and metabolomic mapping have revealed a network
topology, it is critical that its response to altered gene expression be measured in order to
reveal any connectivity between networks, and also to discover conlpletely new pathways
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that may exist. Profiling of the other gene products upstream of metabolites, including
proteins and mRNA, can aide in these discoveries (Weckwerth, 2003). Regulatory sites
in networks can be seen as those at which metabolite flux occurs. This means that an
enzyme or pair of enzymes with opposite activities work at a common site in a pathway,
and catalyze forward and reverse reactions, causing metabolite concentrations to shift
back and forth between the substrates for the two opposite reactions in a reciprocal
fashion. After identifying these regulatory sites according to metabolite flux, researchers
can use these sites to design genetic perturbation experiments targeting the genes that
code for the forward and reverse enzymes controlling flux. These types of experiments
can reveal a great deal of information about the regulatory mechanisms in pathways, and
throughout the entire system. For example, the identification of the site of glutamine flux
has provided researchers with the perturbation targets of enzymatic catalysts of the
forward and reverse reactions, GOGAT and Glutamate dehydrogenase. The perturbation
of the genes responsible for these, and the analysis of the response will provide
information about the regulatory networks controlling the flow of reduced nitrogen into
metabolism (Stitt and Fernie, 2003).
While linking experimental data to regulatory networks is essential in systems
biology, determining the connectivity between multiple metabolic pathways is also a
required step in the development of a knowledge base encompassing all processes within
a system. Snapshot analysis involves nlultiple sequential analyses of the metabolites in
wild type and genetically altered or perturbed plants simultaneously in an attempt to find
metabolites that display Pearson's correlations. After the presence of Pearson's
correlations has been established, distance maps are generated by using Pearson's
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correlation coefficient to calculate and determine connectivity distances between the
many metabolites analyzed in the snapshot analysis (Weckwerth, 2003).
Computer modeling can be utilized in systems biology to conlpile and integrate
the determinations of processes in various regulatory networks along with the
connectivity maps from snapshot analysis for Pearson's correlations. The generated
models visualize the connectivity between metabolites, pathways, and networks, all in
relation to each other. The computer models also have predictive abilities for the nl0des
of action of unknown genes based on the information that has already been input. This
aspect of computer models makes them very useful for researchers as a guide to help
them design perturbation experiments, because the computer models can predict when the
proteome and metabolome are going to act independently of the transcriptome (Sumner et

al., 2003).
Metabolomic approaches to systems biology can define the metabolic variance
between different subcellular organelles, cells, tissues, and even entire organisms. An
example ofmetabolomic assessment of variance between organisms can be seen in a
study that determined the metabolic variance between Arabidopsis ecotypes and between
mutants of the same line. Interestingly, the study showed that there is greater metabolic
variance between different ecotypes of Arabidopsis than there is between mutants of the
same line (Weckwerth, 2003). The incorporation ofmetabolomics into systems biology
has already begun to advance the amount of knowledge about the integration of complex
biological systems and what factors cause them to function. As more research is
undertaken by systems biologists, this knowledge base of system interactions will
continue to grow, along with its applications to other fields.
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Diet and Nutrition:
Metabolomics offers an approach to the field of diet and nutrition that is far more
sensitive to changes in organismal health than previously used and current methods for
the detection of changes in metabolic status and health due to the components of an
individual's diet. The experimental and analytical techniques utilized by metabolomics
have the potential to greatly advance our understanding of how diet affects metabolism,
and subsequently, the overall status of health in humans. The main focus of most
nutritional research to date has been on identifying the aspects of specific biochemical
pathways that certain dietary nutrients affect. The limited scope of these studies has
prevented nutritionists from discerning the larger connectivity of the multiple pathways
that a food may affect due to its complex composition of multiple compounds (German et

al., 2003a).
The multiple elements nlaking up the foods that humans ingest exert their effects
by up-regulating or down-regulating the expression of numerous genes that are
responsible for metabolic activity. In fact, the field of nutrigenomics is dedicated to
studying the relationship between the molecular makeup of foods and the transcriptome,
resulting from gene expression (German et al., 2003b). Since metabolites are the end
products of gene expression, the concentrations of various metabolites and metabolite
classes are modulated by the genes that are expressed or repressed, and metabolite
concentration measurements can give valuable information about the current metabolic
status or phenotype (Watkins and German, 2002). This metabolomic style approach to
studying the mechanisms of metabolism in relation to dietary components offers a much
wider dynamic range for identifying aspects of human metabolism than the traditional
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approach, and when data in the form of nletabolite concentrations is combined with the
genomics technology of DNA micro arrays that detect expression of thousands of genes
simultaneously, information about biochemical pathways involved and gene functions
can be discerned (German et al., 2003b).
Human populations range across a broad spectrum in respect to the
characteristics of their physical appearances, like skin color, height, weight, hair color,
and many other readily viewable traits, indicating that humans are a very diverse species.
Human metabolism, although not easily visualized like external phenotypes, is no
different, in that humans have great variability in their metabolic response to foods. The
source of diversity across human populations lies within the genomes of different
individuals, where genetic polymorphisms alter the activities of homologous genes in
different people. Nutrigenetics is dedicated to studying the causes of differential
nutritional requirements and metabolic responses to similar foods across human
populations at the genetic level (German et al., 2003a). Metabolomic studies offer a
good platform for the analysis of different individuals to assess their different nutritional
needs (German et al., 2002). This is because it offers a method to eventually identify the
significance of different concentrations of certain metabolites in tissues and blood. Once
enough metabolomic studies have been conducted to give a good understanding of the
overall metabolic system, metabolite levels will be indicative of metabolic pathway
activities and genes expressed, which in tum will give nutritionists enough information
for dietary recomnlendations. Metabolomics could effectively end the era of nutrition in
which dietary recommendations are standardized for entire populations, and begin
another in which people will be able to attain greater overall health through access to
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information about their own bodies and how to manipulate their metabolisms (German et

al., 2003b).
Scientists have identified many biomarkers associated with various metabolic
diseases, and they are the current means of diagnosis, which indicate whether an
individual is or is not in a diseased state. Generally, it has been common practice to
deem individuals "healthy" when diagnostics are unable to detect any of the known
biomarkers for metabolic diseases. Metabolic diseases do not appear spontaneously, but
are caused by long-term metabolite imbalances. Metabolic diseases include
artherosc1erosis, obesity, hypertension, type II diabetes, osteoporosis, and some
inflammatory diseases. While biomarkers for metabolic disease do not appear until late
in the disease state for many diseases, individual metabolite concentrations shift out of
their healthy range long before the establishment of the disease state. In this sense,
metabolomics offers a preventative technology with its capability to predict disease
before onset. The success of this technique has already been proven through the
measurement of blood cholesterol levels to determine the likelihood that an individual
will be affected by the metabolic disease artherosc1erosis. Artherosc1eosis is caused by
chronic imbalances in cholesterol metabolism (German et al., 2003a). Although the use
of cholesterol as a biomarker for artherosc1erosis was successful in many aspects, this
case also shows the need for metabolomic assessments of multiple metabolites, rather
than a single biomarker. There are numerous mechanisms by which cholesterol
accumulation can occur, and different treatments are preferential for each. While
cholesterol level measurement can indicate that an individual is at risk for
artherosc1erosis, it does not specify why this is true, or what to do about it. The reasons
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for cholesterol accumulation can be determined by measuring multiple other sterol
metabolite levels, and the identity of the sterols that have accumulated can in tum
indicate the treatment of choice (German et al., 2003b).
According to German et al. (2002), "metabolomics should be led by the field of
nutrition." Modem nutrition will focus on studies of the genome, proteome, and
metabolome, in respect to changes that occur in each as a response to foods (German et

al., 2002). For these studies to be productive, specialized sampling techniques will be
required, as it is difficult to effectively quantify many metabolites in blood. Lipids are an
example of a metabolite class that is difficult to measure in blood, where results are
skewed in samples smaller than 50J.lL (Watkins and German, 2002). The main barrier
standing in the way of metabolomic implementations in nutrition is the lack of complete
understanding of metabolism. There is not yet a reference source containing information
on all metabolites in the human body, but an integrated database with information linking
metabolite structures, metabolite concentrations, protein levels, mRNA levels, and genes
to biochemical pathways would complete the data set required for analysis to completely
understand the nletabolic processes in humans (German et al., 2003a). In assembling this
database, it is preferable to organize metabolites in classes for analysis due to their
involvement in similar metabolic events. This has already been done with lipids,
allowing them to be quantified accurately in blood using the size of each fatty acid chain
as a reference (German et al., 2003b). Scientists should agree on a standard for data
storage so that their data can be conlpiled easily into one central database, and interpreted
after data sets are complete. Once complete, these databases will enable nutritionists to
identify metabolic differences among popUlations, determine the risk of specific
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metabolic diseases, and construct individual diets suited for each person with the goal of
improving the overall health of humans. Greater understanding of human metabolism
will be beneficial to entire populations, not just to individuals with metabolic diseases
(German et al., 2002).

Conclusion:
The study of the metabolome and the fluctuations that occur in its metabolite
content can provide massive amounts of data, which can be analyzed to produce great
amounts of information about the biochemical processes that occur within organisms,
organs, tissues, cells, and subcellular organelles. The interpretation of data collected in
metabolomic studies has the potential to advance a wide variety of scientific research
objectives through the discovery of new biomarkers for disease diagnosis, identification
of new targets for drug therapy in disease, discovery of naturally occurring therapeutic
agents, determination of the possible toxic effects of drug treatments, assignment of
functional annotations to unknown genes, understanding of all processes within entire
biological systems, and implementation of individual diets most suitable for particular
nutritional needs. In order for these possible advancements to be made through
metabolomics, a couple of things need to happen first. An integrated set of technologies
that is well suited for the detection, quantification, and identification of all metabolite
abundances and classes must be established for complete metabolomic analysis.
Reference sources that link metabolites to all of the states that they are associated with
and clearly define the meaning of their relative abundances must be constructed as well.
The best way to achieve this is through the creation of a database that links different
concentrations of each individual metabolite to the different healthy or diseased states,
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gene expressions, biochemical pathways, and integrated networks that they are associated
with throughout each organism under study. The diverse set of potential scientific
advancements based on metabolomics will be realized only after the invention of ideal
assessment technologies and establishnlent of good reference sources for all metabolites.
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